It has been previously shown that treatment with TIC10/ONC201 yields an enhanced transcriptional activity for TRAIL in cancer cells which in turn has been postulated to be responsible for part of the anti-neoplastic activity attributed to this compound [4]. This evidence concerns the gene TNFSF10 and cancer.